# Open-label Study of Curcumin C-3 Complex in Schizophrenia

> **NCT01875822** · PHASE1,PHASE2 · COMPLETED · sponsor: **Woodbury, Michel, M.D.** · enrollment: 17 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Depression

## Interventions

- **DIETARY_SUPPLEMENT:** Super-Curcumin

## Key facts

- **NCT ID:** NCT01875822
- **Lead sponsor:** Woodbury, Michel, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-10
- **Final completion:** 2012-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2013-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875822, "Open-label Study of Curcumin C-3 Complex in Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01875822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*